Computing the Cost of Care per Patient per Day for Patients With Metastatic Neuroendocrine Neoplasms.

The CCPD methodology was effective in studying cancer care value in NENs. Systemic therapy, specifically somatostatin analogs, was the primary driver of cost, and intense monitoring and higher-cost care did not improve survival outcomes.